Methods: A decision analytic model was constructed from the Australian health care system perspective to compare costs and outcomes of the 3 clinical decision rules compared with Australian and New Zealand usual care. The study involved multicenter recruitment from 10 Australian and New Zealand hospitals; recruitment was based on the Australian Pediatric Head Injury Rules Study involving 18,913 children younger than 18 years and with a head injury, and with Glasgow Coma Scale score 13 to 15 on presentation to emergency departments (EDs). We determined the cost-effectiveness of the 3 clinical decision rules compared with usual care.
INTRODUCTION Background
Pediatric head injury is a common emergency department (ED) presentation. 1, 2 Despite high prevalence, few children have a serious outcome. 3, 4 Most head injuries are mild, although some children may be at risk of preventable adverse outcomes. [5] [6] [7] Cranial computed tomography (CT) scanning offers a sensitive method for the identification of intracranial injuries and is the criterion standard investigation for the diagnosis of traumatic brain injuries. 2, 7 Early identification of traumatic brain injury can help avert further brain damage by directing appropriate care. 2, 7 Early imaging has been associated with improved outcomes and reduces hospital admissions by assisting in traumatic brain injury diagnosis.
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Editor's Capsule Summary What is already known on this topic Pediatric head injury computed tomography (CT) clinical decision rules have been popularized.
What question this study addressed
Are any of these clinical decision rules more costeffective than unstructured clinical judgment?
What this study adds to our knowledge In this Australian and New Zealand decision analysis model based on 18,913 injured children, the costeffectiveness was similar between the 3 clinical decision rules and unstructured clinical judgment.
How this is relevant to clinical practice
In Australia and New Zealand, pediatric head CT clinical decision rules are not more cost-effective than unstructured clinical judgment.
sedation to prevent movement, with risk of airway and hemodynamic compromise. 2, 10 Rates of CT scans for the assessment of pediatric head injury have increased considerably in recent decades. 1, 7, 10, 11 In addition to health risks, there are cost implications for EDs and the health care system more broadly.
Pediatric clinical decision rules have been derived to help clinicians make decisions concerning CT. These aim to avoid scanning without missing traumatic brain injury and include features of patient history and examination. Several systematic reviews 2, 8, 11 indicate that the most sensitive are the Children's Head Injury Algorithm for the Prediction of Important Clinical Events (CHALICE), 4 the Pediatric Emergency Care Applied Research Network (PECARN) rule 1 and the Canadian Assessment of Tomography for Childhood Head Injury (CATCH). 10 The foci of the 3 clinical decision rules are different 9 and triggers for CT use vary across different settings. 12 A recent, prospective, multicenter cohort study in Australia and New Zealand determined that the PECARN clinical decision rule had higher point sensitivity than CATCH and CHALICE in a cohort of children with mild head injuries (although they had overlapping confidence intervals). 3 
Goals of This Investigation
We determined the cost-effectiveness of the 3 clinical decision rules compared with usual care in Australia and New Zealand EDs in the evaluation of children with head injury, in a single study population, to guide funding and treatment decisions. The primary outcome is expressed as quality-adjusted life-years incorporating traumatic brain injury and radiation-induced cancer effects.
MATERIALS AND METHODS Study Design and Setting
Decision analytic health economic modeling was undertaken to compare costs, outcomes, and costeffectiveness of the 3 clinical decision rules compared with Australasian usual care, using standard economic evaluation methods. 13 Clinical outcomes and probabilities were based on the Australasian Pediatric Head Injury Rules Study (APHIRST), 3, 9 a multicenter prospective observational study involving 20,137 children presenting with head injuries to 9 tertiary pediatric EDs and one mixed ED across Australia and New Zealand.
14 APHIRST externally evaluated the performance accuracy of the 3 clinical decision rules.
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Selection of Participants
Children were enrolled in APHIRST if they presented to a participating ED between April 11, 2011, and November 30, 2014, and were younger than 18 years and had a head injury. Exclusion criteria were trivial facial injury only, patients referred from ED triage to an external provider, neuroimaging before transfer to a study site, or did not wait to be medically reviewed. 3, 9 This analysis was performed on the APHIRST comparison cohort of 18,913 patients (93.9% of the evaluable cohort) who all had a Glasgow Coma Scale score of 13 to 15 and presented within 24 hours of injury. This cohort represents the group of children who create the greatest dilemma for clinicians, and consequently for whom a clinical decision rule is most likely to be followed. APHIRST patient characteristics are reported in Table 1 .
Interventions
The decision analytic economic model was developed in TreeAge Pro (version 2016; TreeAge Software Inc., Williamstown, MA). The model compares the 3 clinical decision rules and Australasian usual care (Figure 1 ). The usual care strategy was defined as management by clinicians according to current, unstandardized, local practice in Australia and New Zealand, which does not follow any one specific clinical decision rule but may include knowledge derived from the rules more broadly. In our study cohort, the prevalence of clinically important traumatic brain injury (a composite outcome first published in PECARN and previously used to compare head injury clinical decision rules 1, 3 are 8.3% of pediatric ED presentations with suspected head injury. Clinicians were not restricted from using a clinical decision rule, but during recruitment none of the study institutions had formal processes in place for their use. 12 Clinical management and probabilities for usual care tests and hospitalizations were based on observed APHIRST data. For the 3 clinical decision rules, probabilities were derived by applying the rules based on indicated computer algorithms, without the addition of clinical judgment. All 18,913 children were used for the assessment of each clinical decision rule to most closely resemble an actual clinical application in which front-line clinicians would not usually be aware of all rule-specific inclusion and exclusion criteria. Patients were assessed by the clinical decision rules as being at high and low risk according to algorithms and then compared with actual observed outcomes to determine the number of correctly identified and missed brain injuries. This constitutes a pragmatic approach to modeling and compares the rules in a broad and inclusive patient population.
The CHALICE clinical decision rule recommends a dichotomous course of action. If one or more predictor characteristics are present, then a CT is indicated. 2, 4 Similarly, the CATCH clinical decision rule recommends a CT if one or more predictor characteristics are present, even though the article in which the rule was derived separated risk factors into high and medium risk. 2, 10 The PECARN clinical decision rule recommends not to conduct CT in the absence of predictor variables; however, in their presence clinician discretion and observation are used to determine CT use. 1, 2 An adjustment has been developed previously and includes "CT recommended," "observation versus CT on the basis of other clinical factors," and "CT not recommended." 1 1 and a necessary assumption also used in the previously published cost-effectiveness analysis of the PECARN clinical decision rule. Alternative scenarios were evaluated in sensitivity analyses that represent the upper and lower bounds of the effect of allocating all intermediate-risk patients to receive observation followed by CT or observation followed by no CT ( Table 2 ).
The economic model took a lifetime horizon, and both the economic and health care payer perspective comprised the Australian health care system (all hospitals in the study are government funded). The main assumption was that any patient categorized as being at low risk for a traumatic brain injury did not receive a CT and that high-risk children did immediately. In addition, CT scan is the criterion standard and a very accurate diagnostic tool for identification of structural pediatric head injury. APHIRST outcome measures focused on traumatic brain injury and neurosurgery when a CT was required and shown to have positive (abnormal) findings. Our study assumed CT was therefore 100% sensitive and specific for the purpose of the modeling, as have other published economic evaluations. 2, 15 It was assumed that patients categorized as being at low risk (no CT) were discharged home, with the types and lengths of hospital observation and intervening management as recorded in APHIRST. Low-risk patients with missed traumatic brain injuries were assumed to re-present to the hospital (additional ED presentation and a CT).
Outcome Measures
Performance accuracy and clinical outcomes for applying the CATCH, CHALICE, and PECARN clinical decision rules versus usual care for APHIRST have been previously reported 3 but are presented here in the format used for the economic evaluation (Table 2) .
Patient outcomes after traumatic brain injury were estimated by applying the criterion standard Glasgow Outcome Scale-Extended Pediatric, consisting of levels 1 to 8. 16 Transition probabilities from each injury state were based on clinical data for the subset of patients from the APHIRST cohort at the Royal Children's Hospital in Melbourne who sustained traumatic brain injuries (n¼39). After reviewing medical records, a senior ED clinician (J.A.C.) categorized each patient with the Glasgow Outcome Scale-Extended Pediatric. Probabilities were then calculated for different combinations of risk (high or low) and outcome. Patients who did not sustain a traumatic brain injury in either the high-or low-risk groups were assumed to be in full health and were allocated to the highest category, upper good recovery.
Glasgow Outcome Scale-Extended Pediatric utility weights have been previously mapped, 17 and these values were included in the economic model (Table E1 , available online at http://www.annemergmed.com). For patients who sustained brain injuries (clinically important traumatic brain injury with or without neurosurgery) but were missed by either the clinical decision rule or usual care, a utility decrement of 10% was applied to reflect a worse outcome through delayed treatment. Utility values were discounted at 5% per annum, as per Australian convention. 18 The estimated cancer risk of 0.12 and the quality-of-life decrement from a single cranial CT scan of 0.0130 were used according to the results for aged 5 and aged 4 to 9 years, respectively, of a meta-analysis conducted by Stein et al 19 (Table E1 , available online at http://www. annemergmed.com).
Resource costs and associated probabilities are listed in Table 3 . All costs are reported in 2016 Australian dollars, and earlier data were inflated by using the general consumer price index from the Reserve Bank of Australia (July 20, 2017) in accordance with current economic evaluation guidance. 20 An assumed 10% loading, or additional cost, was applied to costs for children whose traumatic brain injury Figure 1 . Economic model (abbreviated). The decision tree shown for usual care is repeated for the CATCH, CHALICE, and PECARN CDRs. CDR, Clinical decision rule; ciTBI, clinically important traumatic brain injury; neurosurgical, ciTBI that requires neurosurgical intervention; nonneurosurgical, ciTBI that does not require neurosurgical intervention; GOS-E Peds outcome, Glasgow Outcome Scale-Extended Pediatrics score; TBI, traumatic brain injury.
(with or without neurosurgery) was missed on initial presentation to account for the likely greater severity attached to an injury that was initially missed compared with the same injury treated immediately.
Primary Data Analysis
The economic evaluation results are presented as a cost per quality-adjusted life-years gained because of traumatic brain injury (short-and long-term management and care) and radiation-induced cancers for the usual care group compared with the 3 clinical decision rules. Incremental cost-effectiveness ratios were calculated to compare each strategy with usual care (difference in costs divided by difference in quality-adjusted life-years). Multiple comparisons of the 3 clinical decision rules were made according to published reporting guidance. 20 Results are reported according to the Consolidated Health Economic Evaluation Reporting Standards guideline. 21 Statistical preparation of original data was performed with Stata (version 14.0; StataCorp, College Station, TX).
Sensitivity Analyses
Probabilistic sensitivity analysis using 1,000 simulations was conducted to investigate the effect of parametric uncertainty (see Table 4 , Figure 2 , and Tables E1 to E3 [available online at http://www.annemergmed.com] for parameters and distributions). The 95% confidence intervals for utility and cost decrements (Table E1 , available online at http://www.annemergmed.com) for missed brain injuries, costs of CT, probability of cancer, Glasgow Outcome Scale-Extended Pediatric utility values, other hospital costs, utility decrement of cancer, cancer cost and Glasgow Outcome Scale-Extended Pediatric costs were used in one-way sensitivity analyses, along with various discount rates (3.5% and 6%) and various cancer latency periods (5 and 20 years).
RESULTS
Usual care, CHALICE, PECARN, and CATCH strategies cost on average AUD $6,390, $6,423, $6,433, and $6,457 per patient, respectively ( Table 4) . The CT scanning rates were 8.3% for usual care, 17.6% for PECARN, 22.0% for CHALICE, and 30.2% for CATCH. From an Australian health care system perspective, the usual care strategy was more effective in detecting traumatic brain injuries and used fewer CT scans. The magnitude of differences in cost and quality-adjusted life-years between the clinical decision rules was small. Usual care was more effective and the least costly and therefore dominated all other strategies. When multiple comparisons of clinical decision rules were made, CHALICE was mostly likely to be cost-effective. The cost-effectiveness results are presented in Table 4 .
Sensitivity analysis showed that when intermediate-risk PECARN patients were allocated to low risk, this rule became closer in cost to usual care, but less effective (because of reduced CT scanning with a greater number of missed injuries). Under this scenario, usual care remained dominant. When intermediate-risk PECARN patients were moved to high risk, this rule became costlier (more CTs) and more effective; however, usual care remained dominant. The model is sensitive to the reallocation of Table 4 and Figure 2A and show that for 61%, 62%, and 60% of simulations, usual care is dominant compared with CATCH, CHALICE, and PECARN, respectively. The cost-effectiveness acceptability curve ( Figure 2B ) shows that for a willingness to pay of $50,000 per quality-adjusted life-year gained, more than 70% of the simulations indicate usual care as the preferred strategy. Cost-effectiveness results remained robust to a number of sensitivity analyses performed (Figure 3) . The usual care strategy remained the dominant strategy under all sensitivity analyses performed. The economic model was most sensitive to the number and cost of cranial CTs, the method for allocation of PECARN intermediate patients, the probability of cancer, and the rate at which future outcomes and costs are discounted. The model trades off the loss of utility and increased costs associated with missed head injuries against the additional cost of imaging. For example, a scenario in which no patients are given a CT leads to a lower price compared with usual care but also fewer quality-adjusted life-years and is not likely costeffective.
LIMITATIONS
This evaluation has several limitations. Cost data from a single center may limit generalizability of results. Nevertheless, results remained robust under sensitivity analyses when cost inputs were varied (Figure 3 ) and the same cost data were applied to usual care and all 3 clinical decision rules. The usual care strategy involves additional periods of patient observation, which are associated with an opportunity cost for another patient who may have been treated in that cubicle or bed in the previous patient's place. The cost of the ED and short stay unit is based on minutes in the cubicle or bed and is incorporated, but additional benefits to another patient are not included. Long-term outcomes for children with neurosurgical traumatic brain injuries were based on a small sample of 39 children from APHIRST; however, the model was not overly sensitive to these utility values. The ability to use original data from the same study to inform the distribution of longer-term outcomes for the economic evaluation could be considered a strength compared with other published economic evaluations that rely on secondary data from a different sample. 15, 22 Treating physicians collected information on all clinical decision rule predictor variables, and it is possible that the collection of data influenced decisionmaking. This may have led to increased effectiveness and therefore cost- Table 4 . Economic evaluation results, each strategy compared with usual care, head-to-head comparison of clinical decision rules, and PECARN alternate allocation to low-and high-risk groups (per child presenting to the ED). QALY, Quality-adjusted life-year; ICER, incremental cost-effectiveness ratio, cost per QALY gained; DOM, dominated strategy (more costly and less effective). *"Dominant" refers to a strategy's being less costly and more effective and therefore preferred. † Note that CATCH is excluded from the multiple comparison of CDRs because of being dominated by the other CDRs (more expensive and less effective). ‡ CHALICE is likely cost-effective for a threshold of less than $50,000 per QALY gained. § All intermediate-risk PECARN patients according to CDR were reallocated to the low-risk modeling group for analysis. { effectiveness of the usual care strategy. However, the overall rate of CT use in the prospective APHIRST study is consistent with a previous retrospective report in the same setting.
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Although we did not find systematic or large-scale use of clinical decision rules, according to a survey we conducted across the PREDICT network before the study, 12 clinicians may have used one or all of the rules for their individual decisionmaking. It remains possible that usual care includes principles from the clinical decision rules gathered through training and practice and that the clinical decision rules represent formal or informal supplements to care. However, widespread use any of the rules should have increased the usual care CT rate over the known long-term stable prestudy baseline; this did not happen. A further limitation relates to the inclusion of clinical discretion in the usual care strategy but not for clinical decision rule strategies, which is inevitable, given the data source. In practice, clinical decision rules are always implemented with clinical discretion. 3, 23 There could be significant variation of usual practices across the 10 sites. The usual care group demonstrates that high-quality decisions are being made by clinicians, but further research using the APHIRST data set would be needed to quantitatively describe usual care.
The rules were applied in a pragmatic manner in which all children in the comparison cohort were made eligible for assessment with each clinical decision rule. The APHIRST cohort assessed with each rule is therefore different from the cohorts in the derivation studies that maintained varied eligibility criteria. This could affect the performance accuracy of the clinical decision rules. However, this method constitutes a real-world approach and may reflect the practices and population in which the rules will be implemented. The economic model relies on a computer algorithm applied to data, and in actual practice clinician judgment would play a significant role. Additionally, the PECARN rule was developed to allow clinician discretion (in regard to observation for intermediate-risk patients 1 ), and in applying PECARN to the data set we have no way of including this. In an actual application of the clinical decision rules, in particular the PECARN rule, all of these factors may result in different probabilities than those imputed, which could affect results. We carefully varied the assumptions around the allocation of PECARN intermediate-risk patients to high-and low-risk categories to assess the effect of this assumption.
DISCUSSION
This economic evaluation for the first time, to our knowledge, directly compares the cost-effectiveness of 3 clinical decision rules and Australasian usual care for the assessment of pediatric head injuries presenting to EDs. The results of the economic modeling demonstrate that the 3 published head injury clinical decision rules are not more cost-effective than Australian and New Zealand usual care strategy. The absolute differences between the rules were small, with the largest difference in bootstrapped cost of $36 (95% confidence interval -$7 to $77) and 0.00097 (95% confidence interval 0.0015 to 0.00044) qualityadjusted life-years per child (equating to an additional 8.5 hours of quality-adjusted life). The cost-effectiveness results were robust under all one-way and probabilistic sensitivity analyses. It is therefore unlikely in this patient setting that the economic evaluation results would suggest the use of any specific clinical decision rule over another.
The strengths of the analysis include a large data set, the use of multiple centers, and that the analysis was able to compare the rules hypothetically using standardized modeling techniques and assumptions. The clinical decision rules were derived to optimize the balance between identifying significant brain injuries and minimizing the exposure of the developing brain to radiation. However, the results presented here do not indicate high value in investing in strategies to switch from usual care, or from one rule to another in our setting. In comparison, a cost-effectiveness analysis conducted in the United States by Nishijima et al 15 reported that PECARN was the dominant strategy compared with usual care (characterized by a 33.8% CT rate). 15 Another costeffectiveness analysis, conducted in the United Kingdom by Holmes et al, 22 investigated CHALICE and PECARN and demonstrated that both are a cost-effective approach. The comparators for this study were not usual practice, but theoretical: CT for all patients and discharge all without testing. It is possible that implementing clinical decision rules in countries where the baseline CT rate is significantly higher than the 8.3% scanning rate in Australia and New Zealand will lead to more advantageous cost-effectiveness ratios. Interventions to appropriately reduce existing imaging rates are likely to be more cost-effective in countries known to have higher unit costs of health care such as the United States. It is likely that patterns of usual care are critical to the choice of clinical decision rule. Initiatives such as Choosing Wisely, [24] [25] [26] which aim to inform evidence based on cost-effective practice choices, should more fully account for usual care contexts when making recommendations. Australian and New Zealand usual care remained cost-effective, indicating no economic imperative for investing in change. We failed to observe important differences in cost or effectiveness between the rules, indicating a lack of economic imperative for switching from any rule to another. Other important factors to the decision are likely to include physician experience and rule-specific sensitivities and specificities for outcomes, which were not considered in this economic evaluation. The use of clinical decision rules outside of specialist pediatric hospitals or by clinicians who are less experienced in evaluating children may generate different results.
In summary, the practice of usual care in our setting is an effective strategy and is cost saving. Compared with usual care in the Australasian specialized pediatric hospital setting, the CATCH, CHALICE, and PECARN clinical decision rules are all projected to scan more children and may miss more neurosurgical and nonneurosurgical traumatic brain injuries that are likely to result in increased hospital costs, with a potential reduction in positive health outcomes. These results were robust under several one-way and probabilistic sensitivity analyses. Further analysis is required to provide a comprehensive definition about what usual care constitutes. This evaluation highlights the importance of understanding usual practice before investing in the implementation of international clinical decision rules derived within other health care settings and countries. work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
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